These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31813753)

  • 1. Strong toll-like receptor responses in cystic fibrosis patients are associated with higher lung function.
    Kosamo S; Hisert KB; Dmyterko V; Nguyen C; Black RA; Holden TD; Radella F; Cotten PA; Goss CH; Aitken ML; Wurfel MM
    J Cyst Fibros; 2020 Jul; 19(4):608-613. PubMed ID: 31813753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variations in toll-like receptor pathway and lung function decline in Cystic fibrosis patients.
    Haerynck F; Mahachie John JM; Van Steen K; Schelstraete P; Van daele S; Loeys B; Van Thielen M; De Canck I; Nuytinck L; De Baets F
    Hum Immunol; 2013 Dec; 74(12):1649-55. PubMed ID: 23994582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
    Southern KW; Patel S; Sinha IP; Nevitt SJ
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells.
    Greene CM; Carroll TP; Smith SG; Taggart CC; Devaney J; Griffin S; O'neill SJ; McElvaney NG
    J Immunol; 2005 Feb; 174(3):1638-46. PubMed ID: 15661927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modifier effect of the Toll-like receptor 4 D299G polymorphism in children with cystic fibrosis.
    Urquhart DS; Allen J; Elrayess M; Fidler K; Klein N; Jaffé A
    Arch Immunol Ther Exp (Warsz); 2006; 54(4):271-6. PubMed ID: 16830219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in lung function and nutritional decline in cystic fibrosis by genotype: An analysis of the Canadian cystic fibrosis registry.
    Leung GJ; Cho TJ; Kovesi T; Hamid JS; Radhakrishnan D
    J Cyst Fibros; 2020 Mar; 19(2):255-261. PubMed ID: 31253541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Airway Mucosal Host Defense Is Key to Genomic Regulation of Cystic Fibrosis Lung Disease Severity.
    Polineni D; Dang H; Gallins PJ; Jones LC; Pace RG; Stonebraker JR; Commander LA; Krenicky JE; Zhou YH; Corvol H; Cutting GR; Drumm ML; Strug LJ; Boyle MP; Durie PR; Chmiel JF; Zou F; Wright FA; O'Neal WK; Knowles MR
    Am J Respir Crit Care Med; 2018 Jan; 197(1):79-93. PubMed ID: 28853905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate immune response in CF airway epithelia: hyperinflammatory?
    Machen TE
    Am J Physiol Cell Physiol; 2006 Aug; 291(2):C218-30. PubMed ID: 16825601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid lung function decline in adults with early-stage cystic fibrosis lung disease.
    Dasenbrook EC; Fink AK; Schechter MS; Sanders DB; Millar SJ; Pasta DJ; Mayer-Hamblett N
    J Cyst Fibros; 2020 Jul; 19(4):527-533. PubMed ID: 31870629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Epididymis Protein 4: A Novel Serum Inflammatory Biomarker in Cystic Fibrosis.
    Nagy B; Nagy B; Fila L; Clarke LA; Gönczy F; Bede O; Nagy D; Újhelyi R; Szabó Á; Anghelyi A; Major M; Bene Z; Fejes Z; Antal-Szalmás P; Bhattoa HP; Balla G; Kappelmayer J; Amaral MD; Macek M; Balogh I
    Chest; 2016 Sep; 150(3):661-72. PubMed ID: 27105680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-17 primes airway epithelial cells lacking functional Cystic Fibrosis Transmembrane conductance Regulator (CFTR) to increase NOD1 responses.
    Roussel L; Rousseau S
    Biochem Biophys Res Commun; 2010 Jan; 391(1):505-9. PubMed ID: 19931506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ivacaftor in cystic fibrosis with residual function: Lung function results from an N-of-1 study.
    Nick JA; St Clair C; Jones MC; Lan L; Higgins M;
    J Cyst Fibros; 2020 Jan; 19(1):91-98. PubMed ID: 31784217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptors 4 and 2 expression in the bronchial mucosa of patients with cystic fibrosis.
    Hauber HP; Tulic MK; Tsicopoulos A; Wallaert B; Olivenstein R; Daigneault P; Hamid Q
    Can Respir J; 2005; 12(1):13-8. PubMed ID: 15776129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis.
    Eickmeier O; Fussbroich D; Mueller K; Serve F; Smaczny C; Zielen S; Schubert R
    PLoS One; 2017; 12(2):e0171249. PubMed ID: 28158236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current concepts of immune dysregulation in cystic fibrosis.
    Rieber N; Hector A; Carevic M; Hartl D
    Int J Biochem Cell Biol; 2014 Jul; 52():108-12. PubMed ID: 24495876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptors in normal and cystic fibrosis airway epithelial cells.
    Muir A; Soong G; Sokol S; Reddy B; Gomez MI; Van Heeckeren A; Prince A
    Am J Respir Cell Mol Biol; 2004 Jun; 30(6):777-83. PubMed ID: 14656745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor-4 genotype influences the survival of cystic fibrosis mice.
    Canale-Zambrano JC; Auger ML; Haston CK
    Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G381-90. PubMed ID: 20522639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperpolarized
    Thomen RP; Walkup LL; Roach DJ; Cleveland ZI; Clancy JP; Woods JC
    J Cyst Fibros; 2017 Mar; 16(2):275-282. PubMed ID: 27477942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Italian Cystic Fibrosis Registry (ICFR). Report 2017-2018].
    Campagna G; Amato A; Majo F; Ferrari G; Quattrucci S; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
    Epidemiol Prev; 2021; 45(3 Suppl 1):1-37. PubMed ID: 34132083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries.
    Volkova N; Moy K; Evans J; Campbell D; Tian S; Simard C; Higgins M; Konstan MW; Sawicki GS; Elbert A; Charman SC; Marshall BC; Bilton D
    J Cyst Fibros; 2020 Jan; 19(1):68-79. PubMed ID: 31196670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.